← Open Payments lookup

CARRIE PORTERFIELD: Open Payments

NPI 1467078790 · CORINTH, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,529 in 134 payments from 16 companies in 2025. Trend: 2023 $1,707 · 2024 $2,353 · 2025 $2,529

Food & beverage: $2,430Education: $99
CompanyPaymentsAmount
Janssen Biotech, Inc.17$402
ABBVIE INC.26$400
Salix Pharmaceuticals, a division of Bausch Health US, LLC19$257
Takeda Pharmaceuticals U.S.A., Inc.12$235
Madrigal Pharmaceuticals9$225
QOL Medical, LLC9$224
GENZYME CORPORATION10$201
Aimmune Therapeutics, Inc.10$186
Celltrion USA Inc.9$137
Phathom Pharmaceuticals, Inc.5$93

Products named: TREMFYA, DUPIXENT, XIFAXAN, ENTYVIO, REZDIFFRA, Sucraid, RINVOQ, VEGZELMA.

Industry payments across MS — which companies pay providers there.